|
 |
About the conference:
Many drugs which are prescribed to children have not been adequately studied in the paediatric population. The lack of specific drugs is now a long-standing international problem. This has resulted in changes in legislation and updated regulatory guidance ensuring that medicines for use in children are of high quality, ethically researched and authorised appropriately. Pharmaceutical companies are now required to produce medicines specifically aimed at 0-17 year olds which has resulted in an increase in paediatric clinical trials.
SMi’s 6th annual conference on Paediatric Clinical Trials explores a range of key issues relating to the involvement of children in pharmaceutical development. There will be a strong focus on operational considerations when designing studies and an update on international regulations governing their conduct. There will also be a focus on ethical issues surrounding the increase in outsourcing clinical investigations to developing countries. Attendees will have access to presentations from a variety of senior professionals working in industry and renowned academic experts.
|
Our expert speaker line-up includes:
Klaus Rose, Paediatric Drug Development Consultant, Klausrose Consulting
Jane Lamprill, Paediatric Research Advisor & Trainer, Paediatric Research Consultancy
Philippe Auby, Director, International Clinical Research, Paediatric Neuropsychiatry, Lundbeck
Lisa Moore-Ramdin, Senior Medical Advisor, Paediatric Vaccines, GlaxoSmithKline
Sabine Desset-Brethes, Project Leader, Pharmaceutical & Analytical Development, Novartis
Georg Schmitt, Head of Toxicology & NCS Paediatrics, F. Hoffman-La Roche
David McIntosh, Global Scientific Affairs Senior Expert, Novartis
Stephen Heaton, Head of Safety Risk Management Planning & Coordination, Bayer Healthcare
Thomas Hassall, Senior Director, Regulatory Policy & Intelligence, Abbott Laboratories
Michael Bolger, Chief Scientist, Simulations Plus, Inc.
Philippa Smit-Marshall, Vice President and General Manager Paediatrics and Medical Sciences, PharmaNet
Steve Pinder, Managing Director, Envestia
Thorsten Ruppert, Senior Manager, Research Development Innovation, VFA
Joseph Standing, Paediatric Clinical Lecturer, School of Pharmacy, University College London
Dirk Matthys, Head of Paediatrics, Ghent University Hospital
Michael Beresford, Professor in Child Health, University of Liverpool
|
Events Home Page
